GE Healthcare (NYSE:GE) recently announced that it has collaborated with Spectronic Medical to make AI-based software for more precise cancer treatment planning.
Spectronic Medical’s AI-based software can be used with GE Healthcare’s AIR Recon DL technology for MR-only based radiotherapy planning for better soft tissue differentiation than traditional CT.
Get the full story on our sister site, MassDevice.
GE Healthcare (NYSE:GE) recently announced that it has collaborated with Spectronic Medical to make AI-based software for more precise cancer treatment planning.
Spectronic Medical’s AI-based software can be used with GE Healthcare’s AIR Recon DL technology for MR-only based radiotherapy planning for better soft tissue differentiation than traditional CT.
About 60% of cancer patients require radiation therapy, which requires high-quality images to target lesions precisely and preserve healthy tissues. CT images are the gold standard for radiation, but they don’t have soft-tissue contrast.
“By using an MR image and creating a synthetic CT image, our MRI Planner software is designed to improve accuracy, increasing the precision by which radiotherapy can be delivered to the patient, as well as simplifying the physician’s workflow,” said Spectronic Medical CEO Carl Siversson. “Our customers say the benefits are enormous – it could increase …